The 2024 Carrot IVF Outcomes Study

Outcomes are what matter most in fertility care. The 2024 Carrot IVF Outcomes Study is built on the most comprehensive data set submitted for independent validation across all fertility benefits programs, and shows what's possible when members receive personalized, evidence-based support.

Carrot's IVF results outperform every competitor of scale at the time of publication and significantly surpass national averages. The result for members: healthier singleton pregnancies, fewer cycles, and more live births. The result for employers: better care that translates to measurable savings.

Key findings vs. national averages:

• IVF pregnancy rate: 23% above the national average
• IVF live birth rate: 24% above the national average
• IVF pre-term birth rate: 41% lower than the national average
• IVF multiple birth rate: 63% lower than the national average

Carrot's methodology was independently assessed by Milliman, Inc., a globally respected actuarial firm, and found to be consistent with industry practices for measuring fertility management performance against national benchmarks from the Society of Assisted Reproductive Technology (SART).

Read the full study to see how Carrot is delivering industry-leading outcomes — including our single embryo transfer (SET) rate, IVF pregnancy rate, and pre-implantatio